Spectral Diagnostics (OTCMKTS:EDTXF) Trading Down 0.3% – Should You Sell?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF)’s stock price dropped 0.3% during mid-day trading on Wednesday . The company traded as low as $0.9830 and last traded at $0.9830. Approximately 21,191 shares were traded during trading, an increase of 187% from the average session volume of 7,392 shares. The stock had previously closed at $0.9860.

Spectral Diagnostics Trading Down 0.3%

The company has a market cap of $288.56 million, a P/E ratio of -9.83 and a beta of 0.11. The business’s 50 day simple moving average is $0.98 and its 200 day simple moving average is $0.99.

Spectral Diagnostics (OTCMKTS:EDTXF) last posted its quarterly earnings results on Friday, May 8th. The company reported ($0.01) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.01). The firm had revenue of $0.64 million during the quarter, compared to the consensus estimate of $0.54 million.

About Spectral Diagnostics

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.